CaMKII regulates retinoic acid receptor transcriptional activity and the differentiation of myeloid leukemia cells.
about
A cascade of Ca(2+)/calmodulin-dependent protein kinases regulates the differentiation and functional activation of murine neutrophilsProlonged intracellular accumulation of light-inducible nanoparticles in leukemia cells allows their remote activationEnrichment of chemical libraries docked to protein conformational ensembles and application to aldehyde dehydrogenase 2Genome-wide gene expression profiling in GluR1 knockout mice: key role of the calcium signaling pathway in glutamatergically mediated hippocampal transmissionEmergence of clonal hematopoiesis in the majority of patients with acquired aplastic anemia.Retinoid receptors trigger neuritogenesis in retinal degenerationsLeukemia stem cells: the root of chronic myeloid leukemiaCaMKII γ, a critical regulator of CML stem/progenitor cells, is a target of the natural product berbamineStructure-Based Target-Specific Screening Leads to Small-Molecule CaMKII Inhibitors.Dynamic and combinatorial control of gene expression by nuclear retinoic acid receptors (RARs).Berbamine inhibits the growth of liver cancer cells and cancer-initiating cells by targeting Ca²⁺/calmodulin-dependent protein kinase II.CaMKII-γ mediates phosphorylation of BAD at Ser170 to regulate cytokine-dependent survival and proliferation.Activated Ca2+/calmodulin-dependent protein kinase IIgamma is a critical regulator of myeloid leukemia cell proliferation.Transcriptional integration of TLR2 and TLR4 signaling at the NCoR derepression checkpoint.Activation of the PI3 kinase pathway by retinoic acid mediates sodium/iodide symporter induction and iodide transport in MCF-7 breast cancer cells.Activation of CaMKIIγ potentiates T-cell acute lymphoblastic leukemia leukemogenesis via phosphorylating FOXO3a.Aberrant activation of CaMKIIγ accelerates chronic myeloid leukemia blast crisis.GSK3 inhibitors enhance retinoic acid receptor activity and induce the differentiation of retinoic acid-sensitive myeloid leukemia cells.
P2860
Q28512167-EDF7E3FA-DE04-4C28-9C5B-6F3BA0B1D6D1Q33705552-9B4FBF40-DF26-4E43-AB5D-FC3605DC0E62Q33966870-0768141B-5836-46A1-B960-8776832169CDQ34562195-AF9BC7AE-9572-4857-B3D5-42F05A99BB66Q35613284-0D5DED38-E274-4759-B1D4-70D875C52201Q35648032-D38C28D0-2598-4F1B-90DD-981B6699D0E5Q35650523-A600F58C-4A9A-4074-9EAA-1A82B628D765Q35865075-3E8B3626-E191-401D-AE94-EFB218B9925CQ36332768-6B8E4BD2-B526-4566-9CE2-4B5478A12328Q37201722-916DD00F-54D8-4636-A67D-B2313A548619Q37256772-4046898A-5CE6-40A1-B763-80370A7BB498Q39439482-4DD2792D-8616-4775-8943-AF02DEA2D79AQ39681202-A1A91B6A-8020-431F-BAC8-B3E4782F8805Q39826073-42A3E30D-BE9B-4C5A-B8BF-B5CD2AAF2DB0Q39863167-0E209782-AFF1-45EB-8847-DAA2F3480ED4Q45927212-AA7049BD-ED39-46F0-97AC-8D59B938D6E4Q47627255-F05AFC15-096A-4422-ACE0-6C7F6B1DD654Q54571860-C3B315F2-8C37-466D-957D-7DE4039B58A0
P2860
CaMKII regulates retinoic acid receptor transcriptional activity and the differentiation of myeloid leukemia cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
CaMKII regulates retinoic acid ...... ion of myeloid leukemia cells.
@en
CaMKII regulates retinoic acid ...... ion of myeloid leukemia cells.
@nl
type
label
CaMKII regulates retinoic acid ...... ion of myeloid leukemia cells.
@en
CaMKII regulates retinoic acid ...... ion of myeloid leukemia cells.
@nl
prefLabel
CaMKII regulates retinoic acid ...... ion of myeloid leukemia cells.
@en
CaMKII regulates retinoic acid ...... ion of myeloid leukemia cells.
@nl
P2093
P2860
P356
P1476
CaMKII regulates retinoic acid ...... ion of myeloid leukemia cells.
@en
P2093
LeMoyne Mueller
Steven J Collins
P2860
P304
P356
10.1172/JCI30779
P407
P577
2007-04-12T00:00:00Z